131 related articles for article (PubMed ID: 37720689)
1. Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy.
Henault D; Stephen D; St-Hilaire PA; Messaoudi N; Vandenbroucke-Menu F; Simoneau E; Rong Z; Plasse M; Létourneau R; Roy A; Dagenais M; Lapointe R; Nguyen B; Mes-Masson AM; Soucy G; Turcotte S
Oncoimmunology; 2023; 12(1):2253642. PubMed ID: 37720689
[TBL] [Abstract][Full Text] [Related]
2. Tumor MHC class I expression improves the prognostic value of T-cell density in resected colorectal liver metastases.
Turcotte S; Katz SC; Shia J; Jarnagin WR; Kingham TP; Allen PJ; Fong Y; D'Angelica MI; DeMatteo RP
Cancer Immunol Res; 2014 Jun; 2(6):530-7. PubMed ID: 24894090
[TBL] [Abstract][Full Text] [Related]
3. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CD73 expression in resected colorectal cancer liver metastasis.
Messaoudi N; Cousineau I; Arslanian E; Henault D; Stephen D; Vandenbroucke-Menu F; Dagenais M; Létourneau R; Plasse M; Roy A; Lapointe R; Ysebaert D; Trudel D; Soucy G; Stagg J; Turcotte S
Oncoimmunology; 2020; 9(1):1746138. PubMed ID: 32363113
[TBL] [Abstract][Full Text] [Related]
5. Changes in apparent diffusion coefficient and pathological response in colorectal liver metastases after preoperative chemotherapy.
Eriksson S; Bengtsson J; Torén W; Lätt J; Andersson R; Sturesson C
Acta Radiol; 2023 Jan; 64(1):51-57. PubMed ID: 35084232
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the density of tumor-infiltrating lymphocytes in colorectal cancer liver metastases.
Wang E; Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Okazaki Y; Kashiwagi S; Tanaka H; Maeda K
Oncol Lett; 2021 Dec; 22(6):837. PubMed ID: 34712361
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
8. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
Adam R; Bhangui P; Poston G; Mirza D; Nuzzo G; Barroso E; Ijzermans J; Hubert C; Ruers T; Capussotti L; Ouellet JF; Laurent C; Cugat E; Colombo PE; Milicevic M
Ann Surg; 2010 Nov; 252(5):774-87. PubMed ID: 21037433
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
Messaoudi N; Henault D; Stephen D; Cousineau I; Simoneau E; Rong Z; Létourneau R; Plasse M; Dagenais M; Roy A; Lapointe R; Vandenbroucke-Menu F; Kunda R; Ysebaert D; Soucy G; Stagg J; Vermeulen P; Turcotte S
Br J Cancer; 2022 May; 126(9):1329-1338. PubMed ID: 34980880
[TBL] [Abstract][Full Text] [Related]
10. Qualitative and quantitative parameters on hepatobiliary phase of gadoxetic acid-enhanced MR imaging for predicting pathological response to preoperative systemic therapy in colorectal liver metastases.
Gu XL; Cui Y; Wang K; Xing Q; Li XT; Zhu HT; Li ZW; Sun YS
Eur J Radiol; 2022 Dec; 157():110572. PubMed ID: 36327859
[TBL] [Abstract][Full Text] [Related]
11. Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
Lin Q; Ding K; Zhao R; Wang H; Wei Y; Ren L; Ye Q; Cui Y; He G; Tang W; Feng Q; Zhu D; Chang W; Wang X; Liang L; Zhou G; Liang F; Ye F; Wang J; Fan J; Xu J
Eur J Cancer; 2023 Sep; 191():112961. PubMed ID: 37473466
[TBL] [Abstract][Full Text] [Related]
12. Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases.
Sutton TL; Wong LH; Walker BS; Dewey EN; Eil RL; Ibewuike U; Chen EY; Rocha FG; Billingsley KG; Mayo SC
J Surg Oncol; 2022 Jun; 125(8):1260-1268. PubMed ID: 35212404
[TBL] [Abstract][Full Text] [Related]
13. Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases.
Saber R; Henault D; Messaoudi N; Rebolledo R; Montagnon E; Soucy G; Stagg J; Tang A; Turcotte S; Kadoury S
J Transl Med; 2023 Jul; 21(1):507. PubMed ID: 37501197
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.
Cirocchi R; Trastulli S; Boselli C; Montedori A; Cavaliere D; Parisi A; Noya G; Abraha I
Cochrane Database Syst Rev; 2012 Jun; (6):CD006317. PubMed ID: 22696357
[TBL] [Abstract][Full Text] [Related]
15. Conversion therapy with the intent to perform radical local treatment may not be suitable for patients with 10 or more liver metastases from colorectal cancer.
Lin J; Sun H; Zhang W; Hong Z; Lu Z; Pan Z; Hou Z; Peng J
Cancer Med; 2022 Nov; 11(22):4225-4235. PubMed ID: 35466587
[TBL] [Abstract][Full Text] [Related]
16. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
17. Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy.
Cucchetti A; Russolillo N; Johnson P; Tarchi P; Ferrero A; Cucchi M; Serenari M; Ravaioli M; de Manzini N; Cescon M; Ercolani G
BJS Open; 2019 Apr; 3(2):186-194. PubMed ID: 30957066
[TBL] [Abstract][Full Text] [Related]
18. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
